Dapasmart 10 mg (Dapagliflozin)

Description

Introduction

Dapasmart 10 mg (Dapagliflozin) is an oral tablet containing 10 mg of dapagliflozin. It is presented for type 2 diabetes. Dapagliflozin belongs to the sodium–glucose cotransporter 2 (SGLT2) inhibitor group of medicines. This description covers the product details and general clinical information relevant to its active ingredient. A healthcare professional can assess whether the product is appropriate for an individual.

What Is It?

Each Dapasmart 10 mg tablet is presented as containing 10 mg of the active ingredient dapagliflozin. Dapagliflozin is a prescription medicine used to help manage blood glucose in type 2 diabetes. It is usually considered as one part of a broader care plan that may include food choices, physical activity, monitoring and other medicines.

The product’s complete inactive ingredients and detailed tablet characteristics are not specified here. Check the supplied packaging or ask a pharmacist if those details matter because of an allergy or another concern.

How Does It Work?

The kidneys filter glucose from the blood and normally return much of it to the bloodstream. Dapagliflozin blocks SGLT2, a protein involved in this glucose reabsorption. As a result, more glucose passes out of the body in urine, helping to lower blood glucose.

This action can also increase urination and fluid loss. Kidney function may affect how well dapagliflozin lowers blood glucose, so a clinician may assess kidney function when considering and reviewing treatment.

Common Uses

Dapasmart 10 mg is presented for type 2 diabetes. Dapagliflozin may be used to improve blood glucose control alongside diet and physical activity. Depending on clinical needs, it may be used with other diabetes medicines. The choice of treatment depends on a person’s medical conditions, kidney function, current medicines and response to treatment.

Other uses of dapagliflozin as an active ingredient should not be assumed to apply to this specific product. Ask a healthcare professional for product-specific guidance.

Available Strengths

This family is available in 5 mg, 10 mg.

Key Features

• Active ingredient: dapagliflozin.
• Strength: 10 mg of dapagliflozin per tablet.
• Dosage form: oral tablet.
• Presented indication: type 2 diabetes.
• Medicine class: SGLT2 inhibitor.
• Its effect on blood glucose comes from increasing glucose excretion through the kidneys.

Benefits

• Dapagliflozin can help lower blood glucose in people with type 2 diabetes when used within an appropriate treatment plan.
• Its mechanism differs from medicines that increase insulin release, which can be relevant when a clinician considers a combination of treatments.
• The tablet provides an oral formulation of dapagliflozin.

The effect varies between people. These characteristics do not establish that Dapasmart 10 mg will be suitable or effective for every person with type 2 diabetes.

Possible Side Effects

• Passing urine more often can occur because more glucose and fluid leave the body in urine.
• Genital fungal infections, including thrush, may cause itching, irritation or discharge.
• Urinary tract infections may cause burning when passing urine, increased urgency or discomfort.
• Dizziness or symptoms of dehydration may occur, particularly when fluid loss is increased.
• Low blood glucose is more likely when dapagliflozin is used with insulin or a sulfonylurea medicine.
• Rare but serious problems include diabetic ketoacidosis, severe urinary infection, a serious genital or perineal infection, and severe allergic reactions.

Seek urgent medical assessment for vomiting with abdominal pain, unusual tiredness, deep or rapid breathing, or severe pain and swelling around the genital area. A swollen tongue or throat, or difficulty breathing, also needs urgent attention. This is not a complete list of possible side effects.

Precautions

• Tell a healthcare professional about kidney or liver problems, low blood pressure, frequent urinary infections or any previous serious reaction to dapagliflozin.
• Discuss pregnancy, plans to become pregnant or breastfeeding before using this medicine.
• Tell the treating team about vomiting, diarrhoea, fever or difficulty drinking fluids, as illness may increase the risk of dehydration.
• Discuss planned surgery or fasting with the prescriber, who can provide advice about treatment around the procedure.
• Dapagliflozin should not be assumed to be appropriate for type 1 diabetes.

Additional Precautions

• A clinician may check kidney function and review blood glucose results during treatment.
• Tell a healthcare professional promptly about symptoms of a genital or urinary infection, especially when accompanied by fever or feeling unwell.
• Be alert to dizziness, particularly when standing up, and discuss persistent symptoms with a clinician.
• Tell doctors, dentists and pharmacists about dapagliflozin use before procedures or when starting another medicine.
• Check the supplied leaflet for the full ingredient list if there is a history of allergies.

Storage Instructions

• Follow the storage directions on the supplied Dapasmart packaging or leaflet.
• Keep the tablets in their original packaging and away from excess heat and moisture.
• Keep all medicines out of the reach of children.
• Check the expiry date before use and ask a pharmacist how to dispose of unwanted or expired tablets.

Ask a pharmacist for product-specific storage advice if the packaging or its instructions are missing or unclear.

How to Take

• Use Dapasmart 10 mg in accordance with the prescriber’s directions and the dispensing label.
• Swallow the tablet as directed in the instructions supplied with the medicine.
• Continue any blood glucose monitoring plan recommended by the treating clinician.
• Ask a pharmacist or prescriber what to do if a tablet is missed or illness affects eating or drinking.
• Seek professional advice before changing or stopping prescribed diabetes medicines.

The 10 mg strength states how much dapagliflozin is in each tablet. It does not specify an individual dose or treatment duration.

Drug Interactions

• Insulin and sulfonylureas, such as gliclazide, may increase the risk of low blood glucose when combined with dapagliflozin.
• Diuretics, sometimes called fluid tablets, may add to fluid loss and increase the chance of dehydration or low blood pressure.
• Other medicines that lower blood pressure may contribute to dizziness or light-headedness.
• Lithium treatment may require closer review or monitoring when used with dapagliflozin.
• Tell the prescriber or pharmacist about prescription medicines, non-prescription products and supplements.

Interaction risks depend on the medicines and the person taking them. A pharmacist or prescriber can review the full medicine list.

Why Choose This Product?

• It provides dapagliflozin as a 10 mg oral tablet.
• Dapagliflozin has an established glucose-lowering mechanism relevant to type 2 diabetes.
• Its SGLT2 action gives clinicians a treatment option with a mechanism different from insulin and medicines that stimulate insulin release.

Whether this particular product belongs in a treatment plan requires a clinical assessment and a review of the supplied product information.

Frequently Asked Questions (FAQs)

What is the active ingredient?

Dapasmart 10 mg contains dapagliflozin as its active ingredient.

What does the 10 mg strength mean?

It means each tablet is presented as containing 10 mg of dapagliflozin. It is not a personalised dosing instruction.

What condition is this product presented for?

The product is presented for type 2 diabetes.

How does dapagliflozin lower blood glucose?

It reduces glucose reabsorption in the kidneys, allowing more glucose to leave the body in urine.

Is Dapasmart 10 mg insulin?

No. It is a dapagliflozin tablet and belongs to the SGLT2 inhibitor group.

Can dapagliflozin cause low blood glucose?

The risk is greater when it is combined with insulin or a sulfonylurea. A clinician can advise on monitoring.

What symptoms need urgent assessment?

Symptoms such as vomiting with abdominal pain, deep breathing, severe genital pain and swelling, or difficulty breathing need urgent medical assessment.

Can it be used during pregnancy or breastfeeding?

Pregnancy or breastfeeding should be discussed with a healthcare professional before use.

What if a tablet is missed?

Follow the supplied medicine instructions or ask a pharmacist or prescriber. Do not take extra tablets without advice.

How should the tablets be stored?

Follow the supplied pack’s directions, keep the tablets in their original packaging and keep them out of children’s reach.

Related Products

• Dapasmart 5 mg (Dapagliflozin)
• Dapasmart 10 mg (Dapagliflozin)
• Sitagliptin 100 Mg Australia
• Bromocriptine 1.25 mg Australia
• Semaglutide 7 mg Australia
• Acarbose 50 mg Australia